Hepatitis C Virus
Research from Cuba and the United Kingdom add new data to hepatitis C virus body of knowledge
Published in Vaccine Weekly, July 5th, 2006
Study 1: According to a study from Cuba, hepatitis C virus (HCV) core protein enhances the immunogenicity of a co-delivered DNA vaccine encoding HCV structural antigens in mice.
"In the present study, recombinant HCV core proteins enhanced the immune response elicited by a co-delivered DNA vaccine encoding HCV core and envelope proteins. A mixture of the plasmid pIDKE2 and Co. 173, a protein comprising the first 173 amino acids of HCV core, in particular induces a strong humoral response, including antibodies that recognized peptides representing hypervariable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-07-05)
More Articles from Vaccine Weekly
- Allergy Medicine
DNA vaccines and allergic diseases reviewed - Alzheimer Disease Vaccine
Anti-A-beta single-chain antibody reduces amyloid load in Alzheimer mouse model - Escherichia Coli Vaccine
Plant-based vaccine protects against intoxication by Shiga toxin - SARS Vaccine
Amino acid substitution in SARS coronavirus spike protein disrupts binding - Streptococcal Vaccine
Rhesus macaque model to assess Streptococcus pneumoniae vaccines developed - Adaptive Immune Response
IFN-alpha/beta-dependent cross-priming induced by specific toll-like receptor agonists - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
